Literature DB >> 8732284

Differences in agonist and antagonist activities for two indices of metabotropic glutamate receptor-stimulated phosphoinositide turnover.

R Mistry1, R A Challiss.   

Abstract

1. The abilities of the four diastereoisomers of 1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) to stimulate, and the metabotropic glutamate receptor (mGluR) antagonist (+/-)-alpha-methylcarboxyphenylglycine (MCPG) to inhibit, phosphoinositide turnover in neonatal rat cerebral cortex have been studied. Two indices of phosphoinositide cycle activity were assessed; inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) mass accumulation, and total inositol phosphate [3H]-InsPx accumulation (in the presence of Li+) in myo-[3H]-inositol prelabelled slices. 2. The diastereoisomers of ACPD stimulated each response with a rank order of potency of 1S, 3R > 1R, 3R > 1S, 3S >> 1R, 3S. The response to 1R, 3R-ACPD was largely prevented by pre-addition of the NMDA-receptor antagonist, MK-801, or omission of extracellular Ca2+, suggesting that this isomer acts indirectly on phosphoinositide responses through activation of NMDA-type ionotropic glutamate receptors. In contrast, the responses to 1S, 3R- and 1S, 3S-ACPD were unaffected by prior addition of MK-801, but were blocked by MCPG. 3. The concentration of 1S, 3R-ACPD required to half-maximally stimulate the Ins(1,4,5)P3 response (-log EC50 (M), -4.09 +/- 0.10) was significantly higher than that required to exert a similar effect on [3H]-InsPx accumulation (-log EC50 (M), -4.87 +/- 0.07; P < 0.01; n = 4). A similar marked 8-9 fold discrepancy between these two values was observed for the 1S, 3S isomer, which elicited similar maximal responses to those caused by 1S, 3R-ACPD. 4. Significant differences were also observed with respect to the ability of (+/-)-MCPG (1 mM) to cause a rightward shift in the concentration-response relationships for 1S, 3R-ACPD-stimulated Ins(1,4,5)P3 (5.59 +/- 0.24 fold shift) and [3H]-InsPx (3.04 +/- 0.34 fold shift; P < 0.01; n = 4) responses, giving rise to Kd values of 218 and 490 microM for (+/-)-MCPG antagonism of the respective responses. 5. The potency difference between the 1S, 3R-ACPD-stimulated Ins(1,4,5)P3 and [3H]-InsPx responses was reduced when experiments were performed in nominally calcium-free medium ([Ca2+]e = 2 - 5 microM) and EC50 values were almost identical when extracellular calcium was reduced further by EGTA addition ([Ca2+]e < or = 100 nM). Similarly, the Kd value for (+/-)-MCPG antagonism of the 1S, 3R-ACPD-stimulated [3H]-InsPx response decreased under [Ca2+]e-free conditions, approaching those obtained for the 1S, 3R-ACPD-stimulated Ins(1,4,5)P3 response in the presence of normal [Ca2+]e. 6. These data suggest that estimates of the activities of mGluR agonists and antagonists, derived by measuring phosphoinositide turnover, can differ significantly depending on whether Ins(1,4,5)P3 mass or [3H]-InsPx responses are measured. In particular, the possibility that the mGluR-mediated [3H]-InsPx response may not simply reflect direct receptor/G protein/phosphoinositidase C (PIC) activation, but may also be the consequence of stimulation of a facilitatory Ca2+-influx pathway is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732284      PMCID: PMC1909577          DOI: 10.1111/j.1476-5381.1996.tb15347.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

Authors:  S Nakanishi
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

2.  Involvement of calcium influx in muscarinic cholinergic regulation of phospholipase C in cerebellar granule cells.

Authors:  E del Río; D G Nicholls; C P Downes
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

3.  Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.

Authors:  C M Testa; D G Standaert; A B Young; J B Penney
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

4.  Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1.

Authors:  C Joly; J Gomeza; I Brabet; K Curry; J Bockaert; J P Pin
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

5.  Histamine-induced Ca2+ entry precedes Ca2+ mobilization in bovine adrenal chromaffin cells.

Authors:  T R Cheek; M M Murawsky; K A Stauderman
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro.

Authors:  M R Santi; S Ikonomovic; J T Wroblewski; D R Grayson
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

7.  Facilitatory coupling between a glutamate metabotropic receptor and dihydropyridine-sensitive calcium channels in cultured cerebellar granule cells.

Authors:  P Chavis; J M Nooney; J Bockaert; L Fagni; A Feltz; J L Bossu
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

8.  Reduction of resting K+ current by metabotropic glutamate and muscarinic receptors in rat CA3 cells: mediation by G-proteins.

Authors:  N C Guérineau; B H Gähwiler; U Gerber
Journal:  J Physiol       Date:  1994-01-01       Impact factor: 5.182

9.  Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: subtype-specific coupling to ion channels.

Authors:  S R Ikeda; D M Lovinger; B A McCool; D L Lewis
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

10.  Properties and ionic mechanisms of a metabotropic glutamate receptor-mediated slow afterdepolarization in neocortical neurons.

Authors:  C C Greene; P C Schwindt; W E Crill
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

View more
  1 in total

1.  Effects of varying the expression level of recombinant human mGlu1alpha receptors on the pharmacological properties of agonists and antagonists.

Authors:  E Hermans; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.